EP Wealth Advisors LLC Has $408,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

EP Wealth Advisors LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,438 shares of the medical device company’s stock after purchasing an additional 194 shares during the quarter. EP Wealth Advisors LLC’s holdings in Cooper Companies were worth $408,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Byrne Asset Management LLC bought a new stake in Cooper Companies in the fourth quarter worth approximately $33,000. OFI Invest Asset Management bought a new position in Cooper Companies in the 4th quarter valued at $34,000. New Age Alpha Advisors LLC purchased a new position in shares of Cooper Companies during the 4th quarter valued at $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after buying an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC purchased a new stake in Cooper Companies during the 4th quarter worth about $49,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $84.44 on Tuesday. The stock has a 50 day moving average of $80.40 and a 200 day moving average of $90.65. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The firm has a market cap of $16.89 billion, a PE ratio of 43.30, a PEG ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research analyst reports. Citigroup decreased their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Piper Sandler restated an “overweight” rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.